CytoSorbents Corporation (CTSO)

[Lakersrback]

NO don't think that is the one. The primary endpoint is IL-6 reduction. I'm looking for the one that shows efficacy in 28 day mortality. How can we tout efficacy without a proper trial showing a reduction or perhaps an increase in 28 day mortality...it is all that really counts according to my father in-law's kidney doctor friend or nephrologist for those more medically inclined. Thanks though, the trial you posted didn't appear overwhelmingly worth discussing